Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Study Links Herpes, Alzheimer’s

By Kenny Walter | October 19, 2018

New research shows that Herpes infections may increase the risk of Alzheimer’s disease. In addition, antiviral drugs may reduce the risk of senile dementia in patients with severe herpes infections.

Herpes viruses remain lifelong in neurons and immune cells, reactivating and resurfacing in blisters when a person is rundown by stress or illness.  The majority of people are infected by the Herpes Simplex Virus 1 (HSV1), the cause of cold sores, by the time they reach old age.

“HSV1 could account for 50 percent or more of Alzheimer’s disease cases,” professor Ruth Itzhaki, who has spent over 25 years at the University of Manchester investigating a potential link, said in a statement.

Itzhaki previously found that cold sores occur more frequently in those who carry a gene variant that confers increased risk of Alzheimer’s called APOE-ε4.

“Our theory is that in APOE-ε4 carriers, reactivation is more frequent or more harmful in HSV1-infected brain cells, which as a result accumulate damage that culminates in development of Alzheimer’s,” she said.

While very few countries collect the population data needed to test Itzhaki’s theory, Taiwanese researchers enrolled 99.9 percent of the country’s population in a National Health Insurance Research Database that is being mined for information on microbial infections and disease.

Three studies were published between 2017 and 2018 describing Taiwanese data on the development of senile dementia–which is mainly caused by Alzheimer’s–and the treatment of patients with marked overt signs of infection with HSV or varicella zoster virus (VZV), commonly known as chickenpox.

“The striking results include evidence that the risk of senile dementia is much greater in those who are infected with HSV, and that anti-herpes antiviral treatment causes a dramatic decrease in number of those subjects severely affected by HSV1 who later develop dementia,” Itzhaki said.

The data from Taiwan only applies to the rare severe HSV1 or VZV infections.

The next step will be to study dementia rates amongst people with mild HSV1 infections, including herpes labialis or mild genital herpes.

“Considering that over 150 publications strongly support an HSV1 role in Alzheimer’s, these Taiwan findings greatly justify usage of antiherpes antivirals – which are safe and well-tolerated – to treat Alzheimer’s disease,” Itzhaki said.”They also incentivize development of an HSV1 vaccine, which would likely be the most effective treatment.”

The study was published in Frontiers in Aging Neuroscience.


Filed Under: Neurological Disease

 

Related Articles Read More >

Human study tracks brain’s glymphatic flow in real time, opening Alzheimer’s drug avenues
An 8-year-old patient with gangliosidosis demonstrates improved mobility, walking unassisted on a soccer field after treatment with N-acetyl-L-leucine. (Still from video footage; parental consent obtained for use).
Modified amino acid approved for Niemann–Pick shows promise in early Parkinson’s research
AI-guided hunt points to PHGDH as an upstream drug target in Alzheimer’s disease
Why smaller, simpler molecular glues are gaining attention in drug discovery
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE